Abstract
Introduction: Artemisinin (ART) is a novel antimalarial drug discovered in China that is quick and effective. The World Health Organization (WHO) has recommended ART-based combination therapies (ACT) as first-line drugs for the treatment of Plasmodium falciparum malaria in all malaria endemic countries. This has contributed to the recent significant decline in the global malaria burden. ART resistance was first detected along the Thai-Cambodian border and has been detected across mainland Southeast Asia. The continued spread of ART resistance will threaten malaria control programs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Pan African Medical Journal Conference Proceedings
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
